vs

Side-by-side financial comparison of CME Group (CME) and QWEST CORP (CTBB). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.1B, roughly 1.7× QWEST CORP). CME Group runs the higher net margin — 0.1% vs -187.5%, a 187.5% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -15.0%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -8.6%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Qwest Corporation, doing business as CenturyLink QC, is a Regional Bell Operating Company owned by Lumen Technologies. It was originally named Mountain States Telephone and Telegraph Company, later becoming known as Mountain Bell, then US West Communications, Inc. from 1991 to 2000. It includes the former operations of Malheur Bell, Northwestern Bell and Pacific Northwest Bell as well.

CME vs CTBB — Head-to-Head

Bigger by revenue
CME
CME
1.7× larger
CME
$1.9B
$1.1B
CTBB
Growing faster (revenue YoY)
CME
CME
+29.5% gap
CME
14.5%
-15.0%
CTBB
Higher net margin
CME
CME
187.5% more per $
CME
0.1%
-187.5%
CTBB
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-8.6%
CTBB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
CTBB
CTBB
Revenue
$1.9B
$1.1B
Net Profit
$1.2M
$-2.1B
Gross Margin
67.9%
Operating Margin
0.1%
-183.2%
Net Margin
0.1%
-187.5%
Revenue YoY
14.5%
-15.0%
Net Profit YoY
20.7%
-627.9%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
CTBB
CTBB
Q1 26
$1.9B
Q4 25
$1.6B
$1.1B
Q3 25
$1.5B
$1.1B
Q2 25
$1.7B
$1.1B
Q1 25
$1.6B
$1.2B
Q4 24
$1.5B
$1.3B
Q3 24
$1.6B
$1.3B
Q2 24
$1.5B
$1.3B
Net Profit
CME
CME
CTBB
CTBB
Q1 26
$1.2M
Q4 25
$1.2B
$-2.1B
Q3 25
$908.0M
$176.0M
Q2 25
$1.0B
$277.0M
Q1 25
$956.2M
$284.0M
Q4 24
$874.6M
$391.0M
Q3 24
$912.8M
$365.0M
Q2 24
$883.2M
$378.0M
Gross Margin
CME
CME
CTBB
CTBB
Q1 26
Q4 25
67.9%
Q3 25
65.3%
Q2 25
68.2%
Q1 25
69.3%
Q4 24
71.2%
Q3 24
69.9%
Q2 24
71.6%
Operating Margin
CME
CME
CTBB
CTBB
Q1 26
0.1%
Q4 25
61.8%
-183.2%
Q3 25
63.3%
22.3%
Q2 25
66.7%
33.1%
Q1 25
67.5%
33.7%
Q4 24
62.1%
40.7%
Q3 24
64.6%
38.5%
Q2 24
65.3%
40.3%
Net Margin
CME
CME
CTBB
CTBB
Q1 26
0.1%
Q4 25
71.7%
-187.5%
Q3 25
59.1%
16.1%
Q2 25
60.6%
24.3%
Q1 25
58.2%
24.7%
Q4 24
57.3%
30.2%
Q3 24
57.6%
28.2%
Q2 24
57.6%
28.7%
EPS (diluted)
CME
CME
CTBB
CTBB
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
CTBB
CTBB
Cash + ST InvestmentsLiquidity on hand
$2.4B
$39.0M
Total DebtLower is stronger
$3.4B
$1.7B
Stockholders' EquityBook value
$10.9B
Total Assets
$202.0B
$15.8B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
CTBB
CTBB
Q1 26
$2.4B
Q4 25
$4.5B
$39.0M
Q3 25
$2.6B
$36.0M
Q2 25
$2.1B
$25.0M
Q1 25
$1.5B
$40.0M
Q4 24
$3.0B
$26.0M
Q3 24
$2.4B
$22.0M
Q2 24
$1.9B
$18.0M
Total Debt
CME
CME
CTBB
CTBB
Q1 26
$3.4B
Q4 25
$1.7B
Q3 25
$1.7B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.7B
Q2 24
$1.9B
Stockholders' Equity
CME
CME
CTBB
CTBB
Q1 26
Q4 25
$28.7B
$10.9B
Q3 25
$28.2B
$13.0B
Q2 25
$27.7B
$12.8B
Q1 25
$27.0B
$12.5B
Q4 24
$26.5B
$12.2B
Q3 24
$28.2B
$11.9B
Q2 24
$27.6B
$11.5B
Total Assets
CME
CME
CTBB
CTBB
Q1 26
$202.0B
Q4 25
$198.4B
$15.8B
Q3 25
$187.1B
$17.9B
Q2 25
$179.9B
$17.8B
Q1 25
$157.8B
$17.6B
Q4 24
$137.4B
$17.4B
Q3 24
$137.8B
$17.0B
Q2 24
$123.4B
$16.6B
Debt / Equity
CME
CME
CTBB
CTBB
Q1 26
Q4 25
0.15×
Q3 25
0.13×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.14×
Q3 24
0.14×
Q2 24
0.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
CTBB
CTBB
Operating Cash FlowLast quarter
$402.0M
Free Cash FlowOCF − Capex
$160.0M
FCF MarginFCF / Revenue
14.5%
Capex IntensityCapex / Revenue
22.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$938.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
CTBB
CTBB
Q1 26
Q4 25
$1.1B
$402.0M
Q3 25
$968.1M
$427.0M
Q2 25
$1.1B
$480.0M
Q1 25
$1.1B
$453.0M
Q4 24
$1.0B
$548.0M
Q3 24
$1.0B
$627.0M
Q2 24
$776.9M
$548.0M
Free Cash Flow
CME
CME
CTBB
CTBB
Q1 26
Q4 25
$1.1B
$160.0M
Q3 25
$949.7M
$252.0M
Q2 25
$1.0B
$276.0M
Q1 25
$1.1B
$250.0M
Q4 24
$991.7M
$277.0M
Q3 24
$973.2M
$396.0M
Q2 24
$758.7M
$280.0M
FCF Margin
CME
CME
CTBB
CTBB
Q1 26
Q4 25
66.8%
14.5%
Q3 25
61.8%
23.1%
Q2 25
61.5%
24.2%
Q1 25
67.1%
21.7%
Q4 24
65.0%
21.4%
Q3 24
61.4%
30.6%
Q2 24
49.5%
21.3%
Capex Intensity
CME
CME
CTBB
CTBB
Q1 26
Q4 25
2.0%
22.0%
Q3 25
1.2%
16.0%
Q2 25
1.1%
17.9%
Q1 25
0.9%
17.6%
Q4 24
1.7%
20.9%
Q3 24
1.9%
17.9%
Q2 24
1.2%
20.4%
Cash Conversion
CME
CME
CTBB
CTBB
Q1 26
Q4 25
0.96×
Q3 25
1.07×
2.43×
Q2 25
1.03×
1.73×
Q1 25
1.17×
1.60×
Q4 24
1.16×
1.40×
Q3 24
1.10×
1.72×
Q2 24
0.88×
1.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

CTBB
CTBB

Nonrelated Party$665.0M60%
Other$436.0M40%

Related Comparisons